Group 1 - Sanoma Corporation executed a share buyback on June 2, 2025, acquiring 6,000 shares at an average price of €9.47 per share, totaling a cost of €56,820 [1] - The company now holds a total of 788,988 of its own shares following this acquisition [2] - Sanoma's net sales for 2024 were approximately €1.3 billion, with an operational EBIT margin excluding PPA of 13.4% [4] Group 2 - Sanoma is committed to sustainability, aligning its strategy with the UN Sustainable Development Goals and the UN Global Compact [2] - The company offers a range of learning products and services aimed at enhancing educational outcomes for children [3] - Sanoma operates across Europe with a workforce of nearly 5,000 professionals [4]

Core Insights - The company reported a Q1 sales growth of 9.7% at constant exchange rates (CER) and a business EPS of €1.79, indicating a strong start to 2025 [1][3][8] Sales Performance - Pharma launches generated sales of €0.8 billion, reflecting a 43.8% increase, primarily driven by ALTUVIIIO [6] - Dupixent sales reached €3.5 billion, up 20.3%, while vaccine sales amounted to €1.3 billion, up 11.4% due to favorable phasing of Beyfortus [6] - Total IFRS net sales were reported at €9,895 million, representing a 10.8% increase [8] Financial Metrics - Business EPS increased by 17.0% reported and 15.7% at CER, reaching €1.79 [6][8] - IFRS net income rose by 65.2% to €1,872 million, with IFRS EPS reported at €1.52, up 67.0% [8] - Free cash flow was reported at €1,029 million [8] Pipeline and Approvals - The company achieved six regulatory approvals across various therapeutic areas, including immunology, rare diseases, and oncology [6][5] - Significant progress was noted in the pipeline, with new data from mid-stage studies unlocking late-stage studies in asthma and skin diseases [6][5] Capital Allocation and Strategy - The company confirmed its capital allocation strategy, including a share buyback program of €5 billion, with 72% already repurchased [7][4] - The anticipated closing of the sale of a controlling stake in Opella is expected in Q2 [7] Future Outlook - Sales are projected to grow by a mid-to-high single-digit percentage at CER in 2025, with business EPS expected to increase at a low double-digit percentage at CER before share buyback [7]

Group 1 - Sanoma Corporation delivered a total of 10,814 own shares to four employees as part of the Restricted Share Plan 2022−2024 [1] - After the share delivery, Sanoma holds a total of 527,157 own shares [1] - In 2024, Sanoma's net sales amounted to approximately €1.3 billion, with an operational EBIT margin excluding PPA of 13.4% [4] Group 2 - Sanoma is committed to sustainability, aiming to maximize its positive impact on society while minimizing its environmental footprint [2] - The company offers a range of learning products and services, including printed and digital content for various educational levels [3] - Sanoma operates across Europe and employs close to 5,000 professionals [4]